PF-Atlas › Clinical Trials › NCT00006169

Behavioral Treatment of Weight Gain in CF

Behavioral Treatment · Phase 3

Registry ID
NCT00006169
Phase
Phase 3
Status
Completed
Drug / intervention
Behavioral Treatment
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Start
1996-06

About this trial

Behavioral Treatment is evaluated in NCT00006169, a Phase 3 idiopathic pulmonary fibrosis study sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Current status: Completed.

View NCT00006169 on ClinicalTrials.gov →

Explore related

All Behavioral Treatment trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT00006169 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.